Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

Daniel B. Drachman; Jeffrey D. Rothstein

doi:10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5

Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

Daniel B. Drachman, Jeffrey D. Rothstein

School of Medicine

Research output: Contribution to journal › Article › peer-review

107 Scopus citations

Abstract

The pathogenesis of motor neuron loss in amyotrophic lateral sclerosis (ALS) is thought to involve both glutamate-mediated excitotoxicity and oxidative damage due to the accumulation of free radicals and oilier toxic molecules. Cyclooxygenase-2 (COX-2) may play a key role in these processes by producing prostaglandins, which trigger astrocytic glutamate release, and by inducing free radical formation. We tested the effects of COX-2 inhibition in an organotypic spinal cord culture model of ALS. The COX-2 inhibitor (SC236) provided significant protection against loss of spinal motor neurons in this system, suggesting that it may be useful in the treatment of ALS.

Original language	English (US)
Pages (from-to)	792-795
Number of pages	4
Journal	Annals of neurology
Volume	48
Issue number	5
DOIs	https://doi.org/10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5
State	Published - 2000

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5

Cite this

@article{0ca683ac8593488183c984b4a3de55ae,

title = "Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis",

abstract = "The pathogenesis of motor neuron loss in amyotrophic lateral sclerosis (ALS) is thought to involve both glutamate-mediated excitotoxicity and oxidative damage due to the accumulation of free radicals and oilier toxic molecules. Cyclooxygenase-2 (COX-2) may play a key role in these processes by producing prostaglandins, which trigger astrocytic glutamate release, and by inducing free radical formation. We tested the effects of COX-2 inhibition in an organotypic spinal cord culture model of ALS. The COX-2 inhibitor (SC236) provided significant protection against loss of spinal motor neurons in this system, suggesting that it may be useful in the treatment of ALS.",

author = "Drachman, {Daniel B.} and Rothstein, {Jeffrey D.}",

year = "2000",

doi = "10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5",

language = "English (US)",

volume = "48",

pages = "792--795",

journal = "Annals of neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

AU - Drachman, Daniel B.

AU - Rothstein, Jeffrey D.

PY - 2000

Y1 - 2000

N2 - The pathogenesis of motor neuron loss in amyotrophic lateral sclerosis (ALS) is thought to involve both glutamate-mediated excitotoxicity and oxidative damage due to the accumulation of free radicals and oilier toxic molecules. Cyclooxygenase-2 (COX-2) may play a key role in these processes by producing prostaglandins, which trigger astrocytic glutamate release, and by inducing free radical formation. We tested the effects of COX-2 inhibition in an organotypic spinal cord culture model of ALS. The COX-2 inhibitor (SC236) provided significant protection against loss of spinal motor neurons in this system, suggesting that it may be useful in the treatment of ALS.

AB - The pathogenesis of motor neuron loss in amyotrophic lateral sclerosis (ALS) is thought to involve both glutamate-mediated excitotoxicity and oxidative damage due to the accumulation of free radicals and oilier toxic molecules. Cyclooxygenase-2 (COX-2) may play a key role in these processes by producing prostaglandins, which trigger astrocytic glutamate release, and by inducing free radical formation. We tested the effects of COX-2 inhibition in an organotypic spinal cord culture model of ALS. The COX-2 inhibitor (SC236) provided significant protection against loss of spinal motor neurons in this system, suggesting that it may be useful in the treatment of ALS.

UR - http://www.scopus.com/inward/record.url?scp=0033762974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033762974&partnerID=8YFLogxK

U2 - 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5

DO - 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5

M3 - Article

C2 - 11079544

AN - SCOPUS:0033762974

SN - 0364-5134

VL - 48

SP - 792

EP - 795

JO - Annals of neurology

JF - Annals of neurology

IS - 5

ER -

Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this